Glucose Sterop

Glucose Sterop is a sterile intravenous solution containing glucose monohydrate as the active ingredient; the product is supplied in an unspecified strength and is formulated as a solution for injection. It is classified as a carbohydrate solution and is used as a volume expander and an energy source in clinical settings across the European Union. It is available by prescription only and is intended for use under medical supervision.

Glucose Sterop is indicated for several clinical situations where rapid glucose delivery or plasma volume expansion is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Fluid and electrolyte replacement in patients needing isotonic solutions. - Parenteral nutrition as a carbohydrate source in total or supplemental feeding. - Intraoperative glucose supplementation to maintain blood glucose levels during surgery. - Support of hemodynamic stability in trauma or burn patients through osmotic volume expansion.

Adverse reactions to Glucose Sterop are generally related to its osmotic and metabolic properties.

Common: - Mild hyperglycemia, especially with large-volume infusions. - Local irritation or pain at the injection site. - Nausea or vomiting. - Electrolyte disturbances such as hyponatremia. - Transient increase in serum osmolality.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Fluid overload with pulmonary edema. - Allergic reactions ranging from urticaria to anaphylaxis. - Hyperosmolar hyperglycemic state in susceptible patients. - Metabolic acidosis in cases of massive infusion.

When prescribing Glucose Sterop, clinicians should consider several safety factors to minimize risk.

- Assess baseline blood glucose and adjust infusion rate accordingly. - Monitor serum electrolytes, particularly sodium and potassium, during therapy. - Use caution in patients with renal or cardiac insufficiency due to risk of fluid overload. - Avoid rapid infusion in neonates and infants because of immature metabolic capacity. - Evaluate for a history of hypersensitivity to glucose solutions before administration. - Consider alternative carbohydrate sources in patients with uncontrolled diabetes. - Ensure proper aseptic technique to prevent contamination.

Glucose Sterop may interact with other agents that affect glucose metabolism or fluid balance.

Avoid: - Concurrent high-dose insulin therapy without close glucose monitoring. - Other hypertonic carbohydrate solutions that could exacerbate hyperglycemia. - Sodium-containing fluids in excess, increasing risk of hypernatremia.

Use with caution: - Diuretics, which may alter electrolyte status during volume expansion. - Corticosteroids, which can raise blood glucose levels. - Beta‑adrenergic agonists that may affect glucose utilization. - Renal replacement therapies that modify fluid and electrolyte balance.